Abstract
To evaluate the efficacy of selection strategies for recombinant Chinese hamster ovary (rCHO) clones undergone with dihydrofolate reductase-mediated gene amplification, rCHO cell lines producing a chimeric antibody were established using two strategies, one based on individual clones and the other based on cell pools. In a selection based on individual clones, cell cloning by limiting dilution method was performed twice, once after a round of selection of parental cell clones and once after obtaining high-producer clones. Thirty parental clones selected from 300 parental clones were cultivated independently throughout the gene amplification procedure. Using this labor-intensive strategy, it took approximately 17 weeks to obtain high-producing clones such as CS11-8 and CS18-3 clones. A selection based on cell pools, in which cell cloning was performed once at the final selection stage, required less effort and time to amplify large numbers of individual parental clones within the pool. However, high-producing clones were lost during the amplification procedure. The antibody expression level of high-producing clones such as PS7-2 and PS7-32 chosen on the basis of cell pools was less than one third of that of CS11-8 and CS18-3 clones. Taken together, a selection strategy based on individual clones is favored for establishment of high-producing rCHO clones because it is more efficient to perform cell cloning at the initial selection stage of parental cell clones.
Similar content being viewed by others
References
Assaraf YG, Schimke RT (1987) Identification of methotrexate transport deficiency in mammalian cells using fluoresceinated methotrexate and flow cytometry. Proc Natl Acad Sci U S A 84:7154–7158
Brezinsky SCG, Chiang GG, Szilvasi A, Mohan S, Shapiro RI, MacLean A, Sisk W, Thill G (2003) A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity. J Immunol Methods 277:141–155
Chung JY, Ahn HK, Lim SW, Sung YH, Koh YW, Park SK, Lee GM (2003) Development of recombinant Chinese hamster ovary cell lines producing human thrombopoietin or its analog. J Microbiol Biotechnol 13:759–766
Davies J, Reff M (2001) Chromosome localization and gene-copy-number quantification of three random integrations in Chinese hamster ovary cells and their amplified cell lines using fluorescence in situ hybridization. Biotechnol Appl Biochem 33:99–105
Flintoff WF, Essani K (1980) Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexate. Biochemistry 19:4321–4327
Flintoff WF, Livingston E, Duff C, Worton RG (1984) Moderate-level gene amplification in methotrexate-resistant Chinese hamster ovary cells is accompanied by chromosomal translocations at or near the site of the amplified DHFR gene. Mol Cell Biol 4:69–76
Gu MB, Kern JA, Todd P, Kompala DS (1992) Effect of amplification of dhfr and lacZ genes on growth and β-glactosidase expression in suspension cultures of recombinant CHO cells. Cytotechnology 9:237–245
Gu MB, Todd P, Kompala DS (1994) Analysis of foreign protein production in recombinant CHO cells. Effect of growth kinetics and cell cycle traverse. Ann N Y Acad Sci 721:194–207
Imanaka T, Aiba S (1981) A perspective on the application of genetic engineering stability of recombinant plasmid. Ann N Y Acad Sci 369:1–14
Kaufman RJ (1990) Selection and coamplification of heterologous genes in mammalian cells. Methods Enzymol 185:537–566
Kaufman RJ, Sharp PA, Latt SA (1983) Evolution of chromosomal regions containing transfected and amplified dihydrofolate reductase sequences. Mol Cell Biol 3:699–711
Kempner ME, Felder RA (2002) A review of cell culture automation. JALA 7:56–62
Kim SJ, Lee GM (1999) Cytogenetic analysis of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure. Biotechnol Bioeng 64:741–749
Kim JH, Bae SW, Hong HJ, Lee GM (1996) Decreased chimeric antibody productivity of KR12H-1 trasfectoma during long-term culture results from decreased antibody gene copy number. Biotechnol Bioeng 51:479–487
Kim SJ, Kim NS, Ryu CJ, Hong HJ, Lee GM (1998) Characterization of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure. Biotechnol Bioeng 58:73–84
Kim NS, Byun TH, Lee GM (2001) Key determinants in the occurrence of clonal variation in humanized antibody expression of CHO cells during dihydrofolate reductase mediated gene amplification. Biotechnol Prog 17:69–75
Lee GM, Varma A, Palsson BO (1991) Application of population balance model to the loss of hybridoma antibody productivity. Biotechnol Prog 7:72–75
Omasa T (2002) Gene amplification and its application in cell and tissue engineering. J Biosci Bioeng 94:600–605
Reff ME (1993) High-level production of recombinant immunoglobulins in mammalian cells. Curr Opin Biotechnol 4:573–576
Renard JM, Spagnoli R, Mazier C, Salles MF, Mandine E (1988) Evidence that monoclonal antibody production kinetics is related to the integral of viable cells in batch systems. Biotechnol Lett 10:91–96
Trill JJ, Shatzman AR, Ganguly S (1995) Production of monoclonal antibodies in COS and CHO cells. Curr Opin Biotechnol 6:553–560
Yoon SK, Hong JK, Lee GM (2004) Effect of simultaneous application of stressful culture conditions on specific productivity and heterogeneity of erythropoietin in Chinese hamster ovary cells. Biotechnol Prog 20:1293–1296
Acknowledgements
This work was supported in part by the Ministry of Health and Welfare (grant 0405-DB00-0101-0004), the Ministry of Science and Technology (2000-N-NL-01-C-228), and the Intelligent Microsystem Center.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jun, S.C., Kim, M.S., Baik, J.Y. et al. Selection strategies for the establishment of recombinant Chinese hamster ovary cell line with dihydrofolate reductase-mediated gene amplification. Appl Microbiol Biotechnol 69, 162–169 (2005). https://doi.org/10.1007/s00253-005-1972-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-005-1972-8